134 related articles for article (PubMed ID: 32506510)
21. Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression.
Fraga-Guedes C; André S; Mastropasqua MG; Botteri E; Toesca A; Rocha RM; Peradze N; Rotmensz N; Viale G; Veronesi P; Gobbi H
Breast Cancer Res Treat; 2015 May; 151(1):131-40. PubMed ID: 25893585
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical Profile of MYC Protein in Pediatric Small Round Blue Cell Tumors.
Chisholm KM; Krishnan C; Heerema-McKenney A; Natkunam Y
Pediatr Dev Pathol; 2017 Jun; 20(3):213-223. PubMed ID: 28521631
[TBL] [Abstract][Full Text] [Related]
23. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
[TBL] [Abstract][Full Text] [Related]
24. [MYC amplification distinguishes between atypical vascular lesion and radiation-induced angiosarcoma of the breast].
Hafner C
Hautarzt; 2013 Jul; 64(7):533-4. PubMed ID: 23744032
[No Abstract] [Full Text] [Related]
25. MET gene copy number alterations and expression of MET and hepatocyte growth factor are potential biomarkers in angiosarcomas and undifferentiated pleomorphic sarcomas.
Schmitz K; Koeppen H; Binot E; Fassunke J; Künstlinger H; Ihle MA; Heydt C; Wardelmann E; Büttner R; Merkelbach-Bruse S; Rüschoff J; Schildhaus HU
PLoS One; 2015; 10(4):e0120079. PubMed ID: 25844809
[TBL] [Abstract][Full Text] [Related]
26. Anti-alpha 1-antichymotrypsin staining of 194 sarcomas, 38 carcinomas, and 17 malignant melanomas. Its lack of specificity as a tumour marker.
Leader M; Patel J; Collins M; Henry K
Am J Surg Pathol; 1987 Feb; 11(2):133-9. PubMed ID: 2433954
[TBL] [Abstract][Full Text] [Related]
27. A Comparison of Outcomes and Prognostic Features for Radiation-Associated Angiosarcoma of the Breast and Other Radiation-Associated Sarcomas.
Mito JK; Mitra D; Barysauskas CM; Mariño-Enriquez A; Morgan EA; Fletcher CDM; Raut CP; Baldini EH; Doyle LA
Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):425-435. PubMed ID: 30703514
[TBL] [Abstract][Full Text] [Related]
28. Programmed Death Ligand 1 (PD-L1) Expression in Malignant Mesenchymal Tumors.
Kösemehmetoğlu K; Özoğul E; Babaoğlu B; Tezel GG; Gedikoğlu G
Turk Patoloji Derg; 2017; 1(1):192-197. PubMed ID: 28832074
[TBL] [Abstract][Full Text] [Related]
29. Not all sarcomas developed in irradiated tissue are necessarily radiation-induced--spectrum of disease and treatment characteristics.
Thariat J; Italiano A; Collin F; Iannessi A; Marcy PY; Lacout A; Birtwisle-Peyrottes I; Thyss A; Lagrange JL
Crit Rev Oncol Hematol; 2012 Sep; 83(3):393-406. PubMed ID: 22138059
[TBL] [Abstract][Full Text] [Related]
30. [Not Available].
Suster D; Ronen S; Peterson JF; Mackinnon AC; Hes O; Suster S; Lin DI
Hum Pathol; 2019 May; 87():28-36. PubMed ID: 30825458
[TBL] [Abstract][Full Text] [Related]
31. The utility of MYC and FLT4 in the diagnosis and treatment of postradiation atypical vascular lesion and angiosarcoma of the breast.
Cornejo KM; Deng A; Wu H; Cosar EF; Khan A; St Cyr M; Tomaszewicz K; Dresser K; O'Donnell P; Hutchinson L
Hum Pathol; 2015 Jun; 46(6):868-75. PubMed ID: 25864386
[TBL] [Abstract][Full Text] [Related]
32. MYC and NOTCH1-positive postradiation cutaneous angiosarcoma of the breast.
Sheu TG; Hunt KK; Middleton LP
Breast J; 2021 Mar; 27(3):264-267. PubMed ID: 33527629
[TBL] [Abstract][Full Text] [Related]
33. Expression of claudin-1 in canine peripheral nerve sheath tumours and perivascular wall tumours. Immunohistochemical study.
Jakab C; Gálfi P; Jerzsele Á; Szabó Z; Németh T; Sterczer Á; Rusvai M; Ózsvári L
Histol Histopathol; 2012 Jul; 27(7):905-17. PubMed ID: 22648546
[TBL] [Abstract][Full Text] [Related]
34. Laryngeal sarcomas: A case series of 5 cases.
AbdullGaffar B; Keloth T
Ann Diagn Pathol; 2018 Dec; 37():35-41. PubMed ID: 30241033
[TBL] [Abstract][Full Text] [Related]
35. Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry.
Kushitani K; Takeshima Y; Amatya VJ; Furonaka O; Sakatani A; Inai K
Pathol Int; 2008 Feb; 58(2):75-83. PubMed ID: 18199156
[TBL] [Abstract][Full Text] [Related]
36. Primary pure spindle cell carcinoma (sarcomatoid carcinoma) of the ovary: A case report with immunohistochemical study.
Giordano G; Berretta R; Silini E
Diagn Pathol; 2016 Aug; 11(1):70. PubMed ID: 27491291
[TBL] [Abstract][Full Text] [Related]
37. Mac387: its non-specificity as a tumour marker or marker of histiocytes.
Loftus B; Loh LC; Curran B; Henry K; Leader M
Histopathology; 1991 Sep; 19(3):251-5. PubMed ID: 1916699
[TBL] [Abstract][Full Text] [Related]
38. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
[TBL] [Abstract][Full Text] [Related]
39. Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions.
Guo T; Zhang L; Chang NE; Singer S; Maki RG; Antonescu CR
Genes Chromosomes Cancer; 2011 Jan; 50(1):25-33. PubMed ID: 20949568
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sites.
Ginter PS; Mosquera JM; MacDonald TY; D'Alfonso TM; Rubin MA; Shin SJ
Hum Pathol; 2014 Apr; 45(4):709-16. PubMed ID: 24457083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
